Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. (Q43782374)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. |
scientific article published in October 2001 |
Statements
1 reference
Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. (English)
1 reference
1 reference
Fan YM
1 reference
Laaksonen R
1 reference
Janatuinen T
1 reference
Vesalainen R
1 reference
Nuutila P
1 reference
Lehtimäki T
1 reference
1 October 2001
1 reference
1 reference
60
1 reference
4
1 reference
319-321
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference